BLGO - BioLargo, Inc.
| Previous Close | 0.420 |
| Open | 0.435 |
| Bid | 0.000 x 0 |
| Ask | 0.000 x 0 |
| Day's Range | 0.423 - 0.435 |
| 52 Week Range | 0.200 - 0.700 |
| Volume | 45,321 |
| Avg. Volume | 97,379 |
| Market Cap | 52.771M |
| Beta | -0.72 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.090 |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | 1997-05-28 |
| 1y Target Est | N/A |
- GlobeNewswire•9 days ago
Dennis Calvert, CEO of BioLargo, Inc., Returns to Uptick Newswire’s Stock Day Podcast to Discuss Company’s Continued Commercial Progress
Dennis Calvert, CEO of BioLargo, Inc. (BLGO) (BioLargo, BLGO, the “Company”) recently spoke with “Stock Day” host Everett Jolly about the company’s commercial progress. BioLargo, Inc. is a dynamic technology incubator and environmental engineering company that develops innovative technology solutions for industry with a focus on clean air, clean water and advanced wound care.
- ACCESSWIRE•19 days ago
BioLargo, Inc. to Present at the 8th Annual LD Micro Invitational
LOS ANGELES, CA / ACCESSWIRE / June 1, 2018 / BioLargo, Inc. (OTCQB: BLGO), an innovator of sustainable science and technology and full-service environmental engineering company today announced that it ...
- GlobeNewswire•last month
BioLargo Achieves Record Product Sales and Revenues in Q1 2018
BioLargo, Inc. (BLGO), an innovator of sustainable science and technology and full-service environmental engineering company, announced that on May 14, 2018, it had filed its 10-Q quarterly report. While we remain confident that we will ultimately receive premarket clearance for our products, we can make no assurance or prediction as to success of Clyra’s efforts, and must wait patiently for the process with the FDA to conclude.
- GlobeNewswire•last month
BioLargo reduces balance sheet liabilities by more than $5,400,000
BioLargo, Inc. (BLGO), an innovator of sustainable science and technology and full-service environmental engineering company, announced that on May 7, 2018, it had reduced the liabilities on its balance sheet by $4,133,378, through the conversion of promissory notes into 15,747,482 shares of common stock. The notes converted had maturity dates ranging from June 1, 2018, through June 20, 2020, and had been issued to investors in the Company’s prior “unit” offerings. BioLargo also reported that it will convert an additional $1,314,380 of debt to equity on June 1, 2018, resulting in the issuance of 3,211,004 shares of common stock (plus shares for accrued interest) for a total reduction of $5,447,758 of debt to equity.
- ACCESSWIRE•2 months ago
BioLargo, Inc. to Present at the Planet MicroCap Showcase 2018 on April 25 in Las Vegas, NV
WESTMINSTER, CA / ACCESSWIRE / April 20, 2018 / BioLargo, Inc., (OTCQB: BLGO), an innovator of sustainable science and technology and full-service environmental engineering company, will present at the ...
- GlobeNewswire•2 months ago
BioLargo, Inc. CEO Dennis Calvert Joins Everett Jolly on Uptick Newswire’s “Stock Day” Podcast
BioLargo, Inc. (BLGO) (“BioLargo” the “Company”), an innovator of sustainable science and technology and full-service environmental engineering company, today announced that its President and CEO Dennis Calvert was interviewed on the Uptick Newswire “Stock Day” podcast with Everett Jolly. BioLargo recently received an important grant from the National Research Council of Canada’s Industrial Research Assistance Program (NRC IRAP).
- GlobeNewswire•2 months ago
BioLargo’s Canadian Subsidiary Receives Funding from the Government of Canada for AOS Pilot Project
BioLargo, Inc. (BLGO), an innovator of sustainable science and technology and full-service environmental engineering company, announced today that its Canadian subsidiary has received a commitment of up to CA$235,000 for a pre-commercial pilot project for its Advanced Oxidation System (AOS) for on-site treatment of poultry processing wastewater at a potential client’s poultry processing facility. The funding will be provided by the National Research Council of Canada Industrial Research Assistance Program (NRC IRAP), Canada's premier industrial innovation assistance program for small and medium-sized enterprises (SMEs). With this support, BioLargo’s AOS has received approximately CA$500,000 in total contributions to date from the NRC IRAP.
- ACCESSWIRE•3 months ago
BioLargo, Inc. to Present at the Inaugural LD Micro Virtual Conference
LOS ANGELES, CA / ACCESSWIRE / March 7, 2018 / BioLargo, Inc. (OTCQB: BLGO), an innovator of sustainable science and technology and full-service environmental engineering company, today announced that ...
- ACCESSWIRE•5 months ago
Industrial Odor Control is Big Business
DENVER, CO / ACCESSWIRE / January 9, 2018 / BioLargo®, Inc. (OTCQB: BLGO): More than one million industrial sites in the U.S. generate unpleasant odors as a normal part of their operations. Although the ...
- ACCESSWIRE•7 months ago
BioLargo Achieves Important Commercial Milestones for Clean Water, Clean Air and Advanced Wound Care Markets
DENVER, CO / ACCESSWIRE / November 28, 2017 / While covering BioLargo (OTCQB: BLGO), Tamarack Advisors has watched the company advance its disruptive technologies in the large markets of water treatment, ...
- ACCESSWIRE•8 months ago
BioLargo's Clyra Medical Division 510(k) Application with FDA Offers New Technology for Advanced Wound Care
DENVER, CO / ACCESSWIRE / October 18, 2017 / The need for effective wound care products has never been greater. Growing global population, rapidly increasing antimicrobial resistance, and the diabetes ...
- ACCESSWIRE•9 months ago
BioLargo Starts World-Class Engineering Division and Secures New Financing to Accelerate Commercialization of its Disruptive Technology in $860B Global Water Market
DENVER, CO / ACCESSWIRE / September 14, 2017 / After a decade of diligent R&D effort supported by a loyal base of investors, BioLargo, Inc. (OTCQB: BLGO) has built an expansive suite of intellectual property ...
- ACCESSWIRE•9 months ago
Commercial Validation Trial Results Confirm BioLargo's Advanced Oxidation System (AOS) as High Performance, Cost-Effective Water Treatment System
DENVER, CO / ACCESSWIRE / September 6, 2017 / BioLargo, Inc. (OTCQB: BLGO) held its third annual "AOS technical symposium" last month, hosting a group of scientists, collaborators, water industry ...